or Try an Advanced Search...

    Science Based Pharmaceutical Stocks List

    Symbol Grade Name % Change
    OGN B Organon & Co. -1.35
    TARO B Taro Pharmaceutical Industries -0.14
    View As Page of Charts
    Related Industries: Drug Manufacturers - General Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Active Pharmaceutical Ingredients Biosimilar Counter Pharmaceutical Products Drug Wholesalers Generic Drug Health Care Health Sciences Health Solutions Life Sciences Managed Care Medication Ointments Patheon Perrigo Pharmaceutical Pharmaceutical Industries Pharmaceutical Products Pharmaceutical Sciences Pharmacology Retail Chain

    Related ETFs - A few ETFs which own one or more of the above listed Science Based Pharmaceutical stocks.

    Symbol Grade Name Weight
    XPH D SPDR S&P Pharmaceuticals ETF 4.99
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 4.21
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 4.16
    CSD A Guggenheim Spin-Off ETF 3.78
    XSHD D PowerShares S&P SmallCap High Dividend Low Volatility Portfolio 3.06
    View all Science Based Pharmaceutical ETFs...
    Compare ETFs
    Compare PILL to CSD Compare PSCH to XSHD Compare XPH to CSD

        Science Based Pharmaceutical Stocks Recent News

        Date Stock Title
        May 7 OGN Organon plans to offer $1B in senior notes
        May 7 OGN Organon Announces Proposed $1.0 Billion Senior Notes Offering
        May 5 OGN Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
        May 4 OGN Organon First Quarter 2024 Earnings: EPS: US$0.79 (vs US$0.70 in 1Q 2023)
        May 2 OGN What Makes Organon (OGN) a New Buy Stock
        May 2 OGN Organon & Co. (OGN) Q1 2024 Earnings Call Transcript
        May 2 OGN Organon declares $0.28 dividend
        May 2 OGN Organon in charts: Strong Q1 with Women's Health up 11% and Biosimilars soaring 47% Y/Y
        May 2 OGN Organon Non-GAAP EPS of $1.22 beats by $0.29, revenue of $1.62B beats by $60M
        May 2 OGN Organon Reports Results for the First Quarter Ended March 31, 2024
        May 1 OGN Organon Q1 2024 Earnings Preview
        Related Industries: Drug Manufacturers - General Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Active Pharmaceutical Ingredients Biosimilar Counter Pharmaceutical Products Drug Wholesalers Generic Drug Health Care Health Sciences Health Solutions Life Sciences Managed Care Medication Ointments Patheon Perrigo Pharmaceutical Pharmaceutical Industries Pharmaceutical Products Pharmaceutical Sciences Pharmacology Retail Chain
        Science Based Pharmaceutical

        Science Based Pharmaceuticals (SBP) is a term used to describe pharmaceuticals that are developed using scientific evidence and research. This includes the use of clinical trials, laboratory studies, and other scientific methods to develop and test drugs. SBP drugs are designed to be safe and effective for the treatment of various medical conditions.

        Browse All Tags